FDA Clears LetsGetChecked ImPress Lancing Device

LetsGetChecked has earned U.S. Food and Drug Administration 510(k) clearance for its LetsGetChecked ImPress lancing device, a single-use blood lancing product that produces microliter capillary whole blood samples.

An alternative to the traditional finger-prick blood draw, the ImPress device won the internationally recognized Red Dot Award in Product Design for its patient-centric design. According to the LetsGetChecked ImPress Device Usability Study, 99% of participants felt no pain. The device is easy to use, requires minimal prep, and combines multiple steps into one action, elevating the patient experience in an often time-consuming process. The LetsGetChecked ImPress enhances sample quality and patient experience from a single press.

“At LetsGetChecked, we are steadfast in our mission to help people live longer, happier lives and the invention of the LetsGetChecked ImPress exemplifies this dedication,” LetsGetChecked Chief Operating Officer Ronan Ryan said. “With this product, we can elevate the patient experience, ensure more consistent delivery of results, and ultimately, improve health outcomes.”

The LetsGetChecked ImPress offers several advantages to healthcare professionals. It produces an optimal blood volume of up to 600ul and quality samples in a point of care setting. For patients, it represents a future where blood draws are simpler, more comfortable, and more accessible than ever before, company executives claim.

LetsGetChecked is a global healthcare solutions company that provides the tools to manage health from home through health testing, genetic sequencing, virtual care, and medication delivery for various health conditions. LetsGetChecked’s end-to-end model includes manufacturing, logistics, lab analysis, physician support, and prescription fulfillment. Founded in 2015, the company empowers people with accessible health information and care to live longer, happier lives.

LetsGetChecked is available nationwide in the United States, the United Kingdom, and most EU countries. It is co-headquartered in Dublin and New York City.